VERTEX PHARMACEUTICALS INC

Ticker: VRTX CUSIP: 92532F100 Class: EQTY

Calydon Capital's Holding History (CIK: 0001759271)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025

Shares 1,540 Value ($000) $686 Avg Close $460.83 Range $416.60 - $510.77

Q3 2024

Shares 777 Value ($000) $364 Avg Close $480.37 Range $456.07 - $510.64

Q1 2020

Shares 4,221 Value ($000) $1,004 Avg Close $229.39 Range $197.47 - $249.85

Q4 2019

Shares 5,226 Value ($000) $1,144 Avg Close $202.38 Range $165.23 - $225.66

Q3 2019

Shares 6,917 Value ($000) $1,164 Avg Close $176.91 Range $165.27 - $188.44

Q2 2019

Shares 3,989 Value ($000) $732 Avg Close $174.82 Range $163.68 - $191.71

Q1 2019

Shares 3,555 Value ($000) $654 Avg Close $184.70 Range $160.95 - $195.81

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2025	1,540	$686	$460.83	$416.60 - $510.77
Q3 2024	777	$364	$480.37	$456.07 - $510.64
Q1 2020	4,221	$1,004	$229.39	$197.47 - $249.85
Q4 2019	5,226	$1,144	$202.38	$165.23 - $225.66
Q3 2019	6,917	$1,164	$176.91	$165.27 - $188.44
Q2 2019	3,989	$732	$174.82	$163.68 - $191.71
Q1 2019	3,555	$654	$184.70	$160.95 - $195.81